This inpatient and outpatient General Clinical Research Center (GCRC) proposes to facilitate the transfer of basic knowledge generated in research laboratories to the clinical arena by elucidating pathogenic mechanisms of disease and evaluating new modes of patient management, and augment investigative collaborations among the clinicians and researchers at The Scripps Research Institute and Scripps Clinic. This application includes thirty-four research projects proposed for study on the Center. Among these protocols are studies to: (1) determine whether immunosuppression with 2-chlorodeoxyadenosine favorably alters the clinical course of relapsing and remitting multiple sclerosis, as it appears to do in patients with the chronic progressive form of this disease; (2) define mechanisms of thrombus formation through the study of platelet interactions with adhesive proteins (in particular, fibrinogen/fibrin, von Willebrand factor and collagen type I) under the influence of shear stress; (3) define the natural history and the response to enzyme replacement therapy in patients with genotypically different forms of Gaucher disease, and explore the possibility of gene replacement therapy in laboratory models; (4) examine the genetic and neurophysiological diversity in biological sensitivity to alcohol by comparing the electroencephalographic responses of low and high alcoholism risk patient populations to a standard alcohol challenge; (5) study the effect of aspirin treatment on the long-term course of ASA- sensitive asthmatics after aspirin desensitization, and analyze the expression and function of monocyte phospholipase A2 in ASA-sensitive subjects; (6) characterize the genetically determined mechanisms that establish the disease phenotype in patients with hereditary angioneurotic edema, analyze the molecular actions of 17alpha-alkylated androgens that are central to therapeutic efficacy, and the efficacy of C1 inhibitor therapy in this disease; (7) produce monoclonal antibodies that neutralize several important human pathogens (HIV-1, measles, herpes simplex, varcella, respiratory syncytial virus, etc.,) as a first step towards the development of antibody-based therapy of these infections; and (8) define the molecular and cellular characteristics of the hepatitis B virus specific cellular immune response during acute and chronic viral hepatitis, and to determine the role it plays in viral clearance and liver cell injury with the objective of developing viral epitope-based immunotherapies to terminate persistent HBV infection in patients with chronic hepatitis;. We anticipate that these and the remaining protocols contained in the application will lead to a greater understanding of disease mechanisms and to the eventual development of new preventive and therapeutic strategies to reduce the incidence and severity of human disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000833-25
Application #
2797065
Study Section
General Clinical Research Centers Committee (CLR)
Program Officer
Knazek, Richard
Project Start
1977-12-01
Project End
2000-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
25
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Winn, Virginia D; Gormley, Matthew; Fisher, Susan J (2011) The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface. Pregnancy Hypertens 1:100-8
Delaney, Joseph A C; Scherzer, Rebecca; Biggs, Mary L et al. (2010) Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS 24:2201-9
Pan, Warren W; Li, Jain-Dong; Huang, Shuang et al. (2010) Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation. J Biol Chem 285:34348-54
Huang, XueSong; Chen, Ling-Yu; Doerner, Astrid M et al. (2009) An atypical protein kinase C (PKC zeta) plays a critical role in lipopolysaccharide-activated NF-kappa B in human peripheral blood monocytes and macrophages. J Immunol 182:5810-5
Mukherjee, Sumanta; Chen, Ling-Yu; Papadimos, Thomas J et al. (2009) Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J Biol Chem 284:29391-8
Chen, Ling-Yu; Pan, Zhixing K (2009) Synergistic activation of leukocytes by bacterial chemoattractants: potential drug targets. Endocr Metab Immune Disord Drug Targets 9:361-70
Chen, Ling-Yu; Pan, Warren W; Chen, Miao et al. (2009) Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: an important microbial pathogenic mechanism. J Immunol 182:2518-24
Ito, Tatsuo; Yadav, Neelu; Lee, Jaeho et al. (2009) Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification. BMC Dev Biol 9:47
Price, Richard W; Parham, Robin; Kroll, Jing Lu et al. (2008) Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther 13:369-74
Dawson, Arthur; Abel, Susan L; Loving, Richard T et al. (2008) CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 4:538-42

Showing the most recent 10 out of 871 publications